These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19732746)

  • 1. Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.
    Wang R; He H; Sun X; Xu J; Marshall FF; Zhau H; Chung LW; Fu H; He D
    Biochem Biophys Res Commun; 2009 Nov; 389(3):455-60. PubMed ID: 19732746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.
    Zhang D; He D; Xue Y; Wang R; Wu K; Xie H; Zeng J; Wang X; Zhau HE; Chung LW; Chang LS; Li L
    Cancer Res; 2011 Mar; 71(6):2193-202. PubMed ID: 21385902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrLZ is expressed in normal prostate development and in human prostate cancer progression.
    Wang R; Xu J; Mabjeesh N; Zhu G; Zhou J; Amin M; He D; Marshall FF; Zhau HE; Chung LW
    Clin Cancer Res; 2007 Oct; 13(20):6040-8. PubMed ID: 17947466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
    Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
    Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.
    Fan Y; Hou T; Dan W; Zhu Y; Liu B; Wei Y; Wang Z; Gao Y; Zeng J; Li L
    Cell Death Differ; 2022 Aug; 29(8):1611-1624. PubMed ID: 35194188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 7. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
    Wang R; Xu J; Saramäki O; Visakorpi T; Sutherland WM; Zhou J; Sen B; Lim SD; Mabjeesh N; Amin M; Dong JT; Petros JA; Nelson PS; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2004 Mar; 64(5):1589-94. PubMed ID: 14996714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of PrLZ overexpression on invasion of prostate cancer LNCaP cells in vitro].
    Zhang D; Li L; Zhang LL; Xue Y; Wang XY; He DL
    Ai Zheng; 2009 May; 28(5):483-6. PubMed ID: 19624875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.
    Shang ZF; Wei Q; Yu L; Huang F; Xiao BB; Wang H; Song M; Wang L; Zhou J; Wang J; Li S
    Oncotarget; 2016 Sep; 7(38):62340-62351. PubMed ID: 27694690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptors in early and castration resistant prostate cancer: friend or foe?
    Pelekanou V; Notas G; Stathopoulos EN; Castanas E; Kampa M
    Hormones (Athens); 2013; 12(2):224-35. PubMed ID: 23933691
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.
    Wu G; Iwamura M; di Sant'Agnese PA; Deftos LJ; Cockett AT; Gershagen S
    Urology; 1998 May; 51(5A Suppl):110-20. PubMed ID: 9610565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells.
    Quayle SN; Sadar MD
    Genomics; 2006 May; 87(5):633-7. PubMed ID: 16439095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.
    Yu L; Shang ZF; Wang J; Wang H; Huang F; Zhang Z; Wang Y; Zhou J; Li S
    Oncotarget; 2015 Aug; 6(24):20356-69. PubMed ID: 26011939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
    Valtonen-André C; Bjartell A; Hellsten R; Lilja H; Härkönen P; Lundwall A
    Biol Chem; 2007 Mar; 388(3):289-95. PubMed ID: 17338636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.
    Chen H; Karam JA; Schultz R; Zhang Z; Duncan C; Hsieh JT
    DNA Cell Biol; 2006 Apr; 25(4):232-45. PubMed ID: 16629596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2.
    Dumont M; Frank D; Moisan AM; Tranchant M; Soucy P; Breton R; Labrie F; Tavtigian SV; Simard J
    Biochim Biophys Acta; 2004 Sep; 1679(3):230-47. PubMed ID: 15358515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer.
    Lau YF; Lau HW; Kömüves LG
    Cytogenet Genome Res; 2003; 101(3-4):250-60. PubMed ID: 14684991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
    Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.